Vor Biopharma
VOR
Vor Biopharma (VOR) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Wedbush | Maintained | Neutral | $27.00 from $18.00 | Aug 12, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $31.00 | May 18, 2026 |
| Wedbush | Maintained | Neutral | $18.00 from $15.00 | May 14, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $31.00 from $32.00 | Apr 15, 2026 |
| Wedbush | Maintained | Neutral | $15.00 from $9.00 | Mar 31, 2026 |
| Jefferies | Initiated Coverage | Buy | $50.00 | Mar 30, 2026 |
| Wells Fargo | Initiated Coverage | Overweight | $30.00 | Mar 19, 2026 |
| Citigroup | Initiated Coverage | Buy | $50.00 | Jan 9, 2026 |
| JP Morgan | Maintained | Overweight | $40.00 from $43.00 | Dec 19, 2025 |
| TD Cowen | Initiated Coverage | Buy | — | Dec 17, 2025 |
| JP Morgan | Initiated Coverage | Overweight | $43.00 | Dec 9, 2025 |
| Wedbush | Initiated Coverage | Neutral | $9.00 | Nov 25, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $32.00 from $55.00 | Nov 14, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $52.00 from $3.00 | Oct 29, 2025 |
| Baird | Upgraded | Neutral → Outperform | $64.00 from $20.00 | Oct 15, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $3.00 | Aug 14, 2025 |
| HC Wainwright & Co. | Upgraded | Neutral → Buy | $3.00 | Jun 30, 2025 |
| Baird | Maintained | Neutral | $1.00 from $0.25 | Jun 27, 2025 |
| Wedbush | Maintained | Neutral | $0.40 | Jun 26, 2025 |
| HC Wainwright & Co. | Downgraded | Buy → Neutral | — | May 9, 2025 |
Frequently asked questions
What is the latest analyst rating on VOR?
On Aug 12, 2026, Wedbush maintained Vor Biopharma at Neutral with a price target of $27.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.